Dr. Callahan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 Glen Echo Rd
Ste 122
Nashville, TN 37215Phone+1 615-297-5300Fax+1 615-297-5301
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1977 - 1980
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1975 - 1977
- Vanderbilt University School of MedicineClass of 1975
Certifications & Licensure
- TN State Medical License 1976 - 2026
- KY State Medical License 2002 - 2008
- AL State Medical License 1980 - 1980
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsReply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and BeyondMichael Szarek, Pierre Amarenco, Alfred Callahan, Larry B. Goldstein, Henrik Sillesen
Journal of the American College of Cardiology. 2020-08-18 - 29 citationsAtorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL TrialMichael Szarek, Pierre Amarenco, Alfred Callahan, David A. DeMicco, Rana Fayyad
Journal of the American College of Cardiology. 2020-05-05 - 26 citationsEffect of High-Dose Atorvastatin on Renal Function in Subjects With Stroke or Transient Ischemic Attack in the SPARCL TrialPierre Amarenco, Alfred Callahan, Vito M. Campese, Larry B. Goldstein, Michael G. Hennerici
Stroke. 2014-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: